.png)
COVID-19 mRNA Vaccines Comirnaty and Spikevax: risk of myocarditis and pericarditis - COVID-19 mRNA Vaccines Comirnaty and Spikevax: risk of myocarditis and pericarditis
COVID-19 mRNA Vaccines Comirnaty and Spikevax: risk of myocarditis and pericarditis
The Italian Medicines Agency would like to inform you of the following:
- Cases of myocarditis and pericarditis have been reported very rarely following vaccination with the COVID-19 mRNA Vaccines Comirnaty and Spikevax.
- The cases primarily occurred within 14 days after vaccination, more often after the second dose and in younger men.
- Available data suggest that the course of myocarditis and pericarditis following vaccination is similar to the course of myocarditis and pericarditis in general.
- Healthcare professionals should be alert to the signs and symptoms of myocarditis and pericarditis.
- Healthcare professionals should advise vaccinated individuals to seek immediate medical attention should they experience chest pain, shortness of breath, or palpitations.
Published on: 19 July 2021

🤝 A Lisbona l’incontro istituzionale tra #AIFA e l’Autorità Nazionale del Farmaco portoghese.
📚 L...
Vai al post →

Davanti a un barattolo di caramelle scegliamo il gusto che ci ispira di più. Fragola, menta, liquiri...
Vai al post →

💜 World Alzheimer's Day - #21settembre
AIFA si tinge di viola per celebrare la Giornata Mondiale de...
Vai al post →

💊 Paracetamolo per il mal di testa, spray per il naso chiuso: i #farmaci da banco rendono facile tr...
Vai al post →

💊 Carenze di #farmaci in UE
🤝#AIFA ospita study visit con rappresentanti di 9 Agenzie regolatorie ...
Vai al post →

Usare i farmaci da banco per il tempo che 𝘵𝘶 ritieni necessario? Non è una buona idea! ❌
📋 Il fo...
Vai al post →